NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Latest News

Blankets, bed-sharing common in accidental baby suffocations

Apr 22, 2019

CHICAGO — Accidental suffocation is a leading cause of injury deaths in U.S. infants and common scenarios involve blankets, bed-sharing with parents and other unsafe sleep practices, an analysis of government data found. These deaths "are entirely preventable. That's the most important point," said Dr. Fern Hauck, a co-author and University of Virginia expert in infant deaths. Among 250 suffocation deaths, roughly 70 percent involved blankets, pillows or other soft bedding that blocked infants' airways. Half of these soft bedding-related deaths occurred in an adult bed where most babies were sleeping on their stomachs. Almost 20 percent suffocated when someone...

Waikiki flood concerns spur push for Hawaii shore protection

Apr 22, 2019

HONOLULU — Hawaii's iconic Waikiki Beach could soon be underwater as rising sea levels caused by climate change overtake its white sand beaches and bustling city streets. Predicting Honolulu will start experiencing frequent flooding within the next 15 to 20 years, state lawmakers are trying to pass legislation that would spend millions for a coastline protection program aimed at defending the city from regular tidal inundations. The highest tides of recent years have sent seawater flowing across Waikiki Beach and onto roads and sidewalks lining its main thoroughfare, and interactive maps of the Hawaiian Islands show that many parts of...

SpaceX capsule suffers 'anomaly,' smoke seen for miles

Apr 22, 2019

CAPE CANAVERAL, Fla. — Officials say SpaceX's new capsule for astronauts suffered an "anomaly" during a routine engine test firing in Florida, causing smoke to be seen for miles. Forty-fifth Space Wing Spokesman Jim Williams tells Florida Today that the anomaly happened Saturday at Cape Canaveral Air Force Station while the SpaceX Crew Dragon capsule was undergoing a "static test fire." Williams says no one was injured and the anomaly was contained. SpaceX's Crew Dragon successfully flew without a crew to the International Space Station in March. Officials had previously said the first flight with astronauts could be as early...

British cyber expert pleads guilty to creating malware

Apr 22, 2019

MILWAUKEE — A British cybersecurity researcher credited with stopping a worldwide computer virus has pleaded guilty to developing malware to steal banking information. Federal prosecutors in Wisconsin and Marcus Hutchins' attorneys said in a joint court filing Friday that the 24-year-old agreed to plead guilty to developing malware called Kronos and conspiring to distribute it from 2012 to 2015. In exchange for his plea to those charges, prosecutors dismissed eight more. "As you may be aware, I've pleaded guilty to two charges related to writing malware in the years prior to my career in security," Hutchins said in a statement...

Polanski asks court to restore his film academy membership

Apr 22, 2019

LOS ANGELES — Roman Polanski asked a judge Friday to restore his membership in the organization that bestows the Academy Awards nearly a year after he was expelled from it for sexual misconduct. Lawyers for the 85-year-old fugitive director petitioned Los Angeles Superior Court to compel the Academy of Motion Picture Arts and Sciences to make him a member in good standing again. In May, the academy made the rare move of expelling Polanski and Bill Cosby, months after ending the membership of disgraced movie mogul Harvey Weinstein. Polanski appealed the decision, and in January the academy rejected his appeal....

Broaden News

About Us

In-Depth Science delivers comprehensive and compelling news and analysis on everything science and technology, seven days a week in a reader-friendly format.

Contact us: sales@indepthscience.com